MedTrace Logo

Clinical Trial to Evaluate the Tolerability and Efficacy of Microencapsulated Calcium Carbonate

NCT03452696 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 208

Last updated 2019-04-08

No results posted yet for this study

Summary

Interventional Clinical trial with food supplement, randomized, double-blind, comparative between microencapsulated calcium, calcium carbonate salts standardized and calcium citrate, in a population of postmenopausal women, lasting 1 month.

Conditions

  • Hypocalcemia; Dietary

Interventions

DIETARY_SUPPLEMENT

Calcium supplement

Calcium supplement for low contribution of elemental calcium in the daily diet

Sponsors & Collaborators

  • Nexentia S.A.S.

    collaborator UNKNOWN

  • Instituto Palacios

    lead OTHER

Principal Investigators

  • Santiago Palacios, PI · Instituto Palacios

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-15
Primary Completion
2019-03-28
Completion
2019-04-03

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03452696 on ClinicalTrials.gov